Cohen & Grigsby Counsels Bayer HealthCare on Sale of Interventional Device Business

On Friday, August 29 Cohen & Grigsby worked with client Bayer HealthCare to complete the company’s sale of its thrombectomy and atherectomy medical device businesses to Boston Scientific Corporation for $415 million. With this sale, Bayer HealthCare’s Medical Care division can concentrate on innovation and growth in Radiology and Diabetes Care, where the business already has a strong presence. Learn more about the sale here.

 

Printable PDF